National Institute of Allergy and Infectious Disease (NIAID) Announces it will Begin a Series of Trials to Gain Insight into Vaccine Development

Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.

The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

With the emergence of the 2009 H1N1 influenza virus, we have undertaken a collaborative and efficient process of vaccine development that is proceeding in stepwise fashion”

— NIAID Director Anthony S. Fauci, M.D.